KAS
ROIV icon

Kemnay Advisory Services’s Roivant Sciences ROIV Stock Holding History

Kemnay Advisory Services’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.4K Sell
209
-853
-80% -$25.2K ﹤0.01% 1113
2026
Q1 		$29.4K Buy
+1,062
New +$27.3K ﹤0.01% 457

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Kemnay Advisory Services's ROIV Position: Q2 2026 in Review

Kemnay Advisory Services reduced its Roivant Sciences (ROIV) stake by 80% in Q2 2026, selling an estimated $25.2K and leaving 209 shares worth $7.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

Kemnay Advisory Services first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. The position peaked at $29.4K in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Kemnay Advisory Services held 209 shares of Roivant Sciences worth $7.4K as of Q2 2026.
  • Kemnay Advisory Services sold 853 Roivant Sciences shares in Q2 2026, an estimated $25.2K.
  • Roivant Sciences made up ﹤0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #1113 holding.
  • Kemnay Advisory Services first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
  • Kemnay Advisory Services's Roivant Sciences position peaked at $29.4K in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.